Graft-Versus-Host Disease
Investigators at Cornell University Target Graft-Versus-Host Disease
Published in Biotech Week, November 9th, 2011
2011 NOV 9 -- According to the authors of a study from New York City, New York, "Factors contributing to infection risk after cord blood transplantation (CBT) include the use of anti-thymocyte globulin (ATG), prolonged neutropenia, and failure to transfer immunity. In the present study, we investigated the potential of double-unit CBT without ATG to reduce the risk of infection and evaluated the nature of serious infections in the first year after CBT using this approach."
"Seventy-two predominantly adult patients underwent CBT for hematologic malignancies; of these, 52 patients received myeloablative conditioning, and 20 received nonmyeloablative...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Biotech Week
Source: Biotech Week (2011-11-09)
More Articles from Biotech Week
- Multiple Sclerosis
Alemtuzumab Lemtrada(TM)* Significantly Reduces Relapses in Multiple Sclerosis vs Interferon Beta-1a in a Phase III Study - Atherosclerosis
AtheroNova Completes Successful Pre-IND Meeting with FDA on AHRO-001 - Biotechnology
BioFlorida's 14th Annual Conference Sets Attendance Record - Biopharmaceuticals
Biopharmaceutical Contract Manufacturing Study Shows Improving Industry Growth Prospects - Nanotubes
Biosensing tool to detect salmonella holds promise for preventing common food poisoning - Biologics
Biosimilar/Follow-on Biologics Market Report & Forecast: A Focus on the US 2011-2020 - More from this issue of Biotech Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
